| Autor: |
Aksu K; Division of Immunology and Allergy, Department of Chest Diseases, University of Health Sciences Atatürk Sanatoryum Training and Research Hospital, Ankara, Turkey., Vural Solak GT; Division of Immunology and Allergy, Department of Chest Diseases, University of Health Sciences Atatürk Sanatoryum Training and Research Hospital, Ankara, Turkey., Mutlu LC; Department of Chest Diseases, Tekirdağ Namık Kemal University Faculty of Medicine, Tekirdağ, Turkey., Mutlu P; Faculty of Medicine, Department of Chest Diseases, Çanakkale 18 Mart University, Çanakkale, Turkey., Vayısoğlu Şahin G; Department of Chest Diseases, Mardin Training and Research Hospital, Mardin, Turkey., Erdem Türe E; Department of Chest Diseases, Ankara Etlik City Hospital, Ankara, Turkey., Yormaz B; Department of Chest Diseases, Selçuk University Faculty of Medicine, Konya, Turkey., Çapraz A; Department of Chest Diseases, Amasya University Faculty of Medicine Sabuncuoğlu Şerafettin Training and Research Hospital, Amasya, Turkey., Coşkun Beyan A; Department of Chest Diseases, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey., Solak Y; Şereflikoçhisar District Health Directorate, Ankara, Turkey., Aksu F; Department of Chest Diseases, University of Health Sciences Atatürk Sanatoryum Training and Research Hospital, Ankara, Turkey. |
| Abstrakt: |
Background: Asthma controller medications can be delivered via pressurized metered dose inhaler (pMDI) or dry powder inhaler (DPI) devices. Objective: This study aimed to evaluate the frequency of exacerbations and satisfaction rate with device use in asthmatics using pMDIs or DPIs. Methods: A multicenter, cross-sectional study was conducted in adults who used pMDIs or DPIs with correct inhaler technique and good adherence for asthma treatment. Demographic and asthma-related characteristics of the subjects and data regarding device satisfaction were collected through a face-to-face interview in the outpatient clinic. Rates of pMDI and DPI users and the data were compared between the two groups. Results: The study included 338 patients (mean age: 48.6 ± 14.5 years, 253 [74.9%] women). Among participants, 96 (28.4%) were using pMDI and 242 (71.6%) were using DPI. The age of patients using pMDI were significantly lower compared with DPI users. No significant difference was observed in terms of device satisfaction and clinical outcomes of asthma between pMDI and DPI users with good inhaler technique and good adherence. Conclusion: More asthmatics use DPIs, however, pMDIs are used in younger asthmatic patients. No significant difference in terms of device satisfaction and clinical outcomes of asthma was observed between pMDI and DPI users. |
